Case study: Will’s story: Valneva’s inactivated COVID-19 Vaccine Trial
For more information about taking part in research please visit the Be Part of Research website.Find out more
Will’s story: Valneva’s inactivated COVID-19 Vaccine Trial
"The pandemic has affected everyone so negatively and we all just want to get back to regular everyday life now, and I feel a key way that we're going to do this is through the vaccination programmes. So I saw the opportunity to take part in the Valneva study in Bristol and I felt like it would be a really good way to do my bit."
Phase 3 of the Valneva vaccine study opened in Bristol in April 2021.
The vaccine is the only inactivated, adjuvanted COVID-19 vaccine in clinical development in Europe.
Will is one of the volunteers taking part in the study. Watch his story of taking part in research: